Grant Number:	5R21CA182659-02 Interpret this number
Primary Investigator:	Andrew, Angeline
Organization:	Dartmouth College
Project Title:	Microrna Dysregulation and Bladder Cancer Prognosis
Fiscal Year:	2015

DESCRIPTION (provided by applicant): MicroRNA dysregulation and bladder cancer prognosis. Bladder cancer is the fourth most common malignancy in U.S. men. More than half of non-muscle invasive urothelial cell carcinoma patients experience recurrent disease. Among the most clinically challenging cases are those with histologies that denote poor differentiation or carcinoma in situ features (high grade Ta, T1, or Tis). Some of these patients have frequently recurring tumors that are refractory to treatment, but it is difficult to predict which patients hae this phenotype. The objective of this proposal is to identify prognostic markers of this rapidly recurrent phenotype in the primary tumor tissue. MicroRNAs (miRNAs) are stable, non-protein coding RNA molecules that are frequently dysregulated during tumorigenesis. No previous miRNA studies in urothelial carcinoma have focused on comprehensively identifying prognostic miRNAs within the clinically challenging, non-muscle invasive tumor types. We have assembled a unique population-based tissue bank of bladder tumors with extensive, long-term recurrence, progression, and survival data from a large epidemiologic cohort encompassing n=1062 non-muscle invasive urothelial cell carcinoma patients. We first plan to identify the miRNAs associated with rapid recurrence by comprehensively assessing primary tumor tissue specimens for miRNA expression levels using small RNA sequence count analysis (RNA-Seq). We will integrate our results with information from the literature to prioritize the prognostic miRNAs. We will technically confirm the priority miRNA expression levels by reverse-transcription and quantitative real-time PCR (qRT-PCR), and will evaluate the miRNA distribution in urothelial carcinoma cells versus other cell-types using in situ hybridization. Finally, we will evaluate the prognostic value of the prioritized miRNA in relation to recurrence, progression and survival using our large population-based case cohort. Successful identification of a prognostic dysregulated miRNA will help tailor management of clinically challenging bladder cancer cases by enabling early detection of rapidly recurrent and refractory phenotypes. The dysregulated miRNAs that we identify are also potentially viable therapeutic targets and could lead to the future development of novel anti-miR or miRNA-replacement therapies for this malignancy.




Identification of Let-7f-5p as a novel biomarker of recurrence in non-muscle invasive bladder cancer.
Authors: Shee K. , Seigne J.D. , Karagas M.R. , Marsit C.J. , Hinds J.W. , Schned A.R. , Pettus J.R. , Armstrong D.A. , Miller T.W. , Andrew A.S. .
Source: Cancer biomarkers : section A of Disease markers, 2020; 29(1), p. 101-110.
PMID: 32623385
Related Citations

MicroRNA Dysregulation and Non-Muscle-Invasive Bladder Cancer Prognosis.
Authors: Andrew A.S. , Karagas M.R. , Schroeck F.R. , Marsit C.J. , Schned A.R. , Pettus J.R. , Armstrong D.A. , Seigne J.D. .
Source: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, 2019 Apr; 28(4), p. 782-788.
EPub date: 2019-01-30.
PMID: 30700445
Related Citations

Hyper-Methylated Loci Persisting from Sessile Serrated Polyps to Serrated Cancers.
Authors: Andrew A.S. , Baron J.A. , Butterly L.F. , Suriawinata A.A. , Tsongalis G.J. , Robinson C.M. , Amos C.I. .
Source: International journal of molecular sciences, 2017-03-02; 18(3), .
EPub date: 2017-03-02.
PMID: 28257124
Related Citations

Complex systems analysis of bladder cancer susceptibility reveals a role for decarboxylase activity in two genome-wide association studies.
Authors: Cheng S. , Andrew A.S. , Andrews P.C. , Moore J.H. .
Source: BioData mining, 2016; 9, p. 40.
EPub date: 2016-12-12.
PMID: 27999618
Related Citations

Detecting gene-gene interactions using a permutation-based random forest method.
Authors: Li J. , Malley J.D. , Andrew A.S. , Karagas M.R. , Moore J.H. .
Source: BioData mining, 2016; 9, p. 14.
EPub date: 2016-04-06.
PMID: 27053949
Related Citations

Expression of tumor suppressive microRNA-34a is associated with a reduced risk of bladder cancer recurrence.
Authors: Andrew A.S. , Marsit C.J. , Schned A.R. , Seigne J.D. , Kelsey K.T. , Moore J.H. , Perreard L. , Karagas M.R. , Sempere L.F. .
Source: International journal of cancer, 2015-09-01; 137(5), p. 1158-66.
EPub date: 2015-02-25.
PMID: 25556547
Related Citations

Genetic polymorphisms modify bladder cancer recurrence and survival in a USA population-based prognostic study.
Authors: Andrew A.S. , Gui J. , Hu T. , Wyszynski A. , Marsit C.J. , Kelsey K.T. , Schned A.R. , Tanyos S.A. , Pendleton E.M. , Ekstrom R.M. , et al. .
Source: BJU international, 2015 Feb; 115(2), p. 238-47.
EPub date: 2014-03-26.
PMID: 24666523
Related Citations

Functional dyadicity and heterophilicity of gene-gene interactions in statistical epistasis networks.
Authors: Hu T. , Andrew A.S. , Karagas M.R. , Moore J.H. .
Source: BioData mining, 2015; 8, p. 43.
EPub date: 2015-12-21.
PMID: 26697115
Related Citations

A screening-testing approach for detecting gene-environment interactions using sequential penalized and unpenalized multiple logistic regression.
Authors: Frost H.R. , Andrew A.S. , Karagas M.R. , Moore J.H. .
Source: Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing, 2015; , p. 183-94.
PMID: 25592580
Related Citations

Clinicopathological correlates of Gli1 expression in a population-based cohort of patients with newly diagnosed bladder cancer.
Authors: Sverrisson E.F. , Zens M.S. , Fei D.L. , Andrews A. , Schned A. , Robbins D. , Kelsey K.T. , Li H. , DiRenzo J. , Karagas M.R. , et al. .
Source: Urologic oncology, 2014 Jul; 32(5), p. 539-45.
EPub date: 2014-05-22.
PMID: 24856810
Related Citations

Functional genomics annotation of a statistical epistasis network associated with bladder cancer susceptibility.
Authors: Hu T. , Pan Q. , Andrew A.S. , Langer J.M. , Cole M.D. , Tomlinson C.R. , Karagas M.R. , Moore J.H. .
Source: BioData mining, 2014-04-11; 7(1), p. 5.
EPub date: 2014-04-11.
PMID: 24725556
Related Citations

A system-level pathway-phenotype association analysis using synthetic feature random forest.
Authors: Pan Q. , Hu T. , Malley J.D. , Andrew A.S. , Karagas M.R. , Moore J.H. .
Source: Genetic epidemiology, 2014 Apr; 38(3), p. 209-19.
EPub date: 2014-02-17.
PMID: 24535726
Related Citations

Body mass and smoking are modifiable risk factors for recurrent bladder cancer.
Authors: Wyszynski A. , Tanyos S.A. , Rees J.R. , Marsit C.J. , Kelsey K.T. , Schned A.R. , Pendleton E.M. , Celaya M.O. , Zens M.S. , Karagas M.R. , et al. .
Source: Cancer, 2014-02-01; 120(3), p. 408-14.
EPub date: 2013-10-10.
PMID: 24122218
Related Citations